The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens

American Journal of Gastroenterology

Volumn 107, Issue 3, 2012, Pages 473-483

  Sung, Young Kyung ^a   Lee, Jong Kyun ^a   Lee, Kwang Hyuck ^a   Lee, Kyu Taek ^a   Kang, Cheol In ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTAZIDIME; CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE; METICILLIN;

ADULT; AEROMONAS; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM; BILIARY TRACT DRAINAGE; BILIARY TRACT INFECTION; CITROBACTER; COMMUNITY ACQUIRED INFECTION; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION; KLEBSIELLA; KLUYVERA; MAJOR CLINICAL STUDY; MALE; MORGANELLA; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEUS; PSEUDOMONAS; RAOULTELLA; SERRATIA; STAPHYLOCOCCUS; STREPTOCOCCUS; SURVIVAL;

AGED; BACTEREMIA; CHI-SQUARE DISTRIBUTION; CHOLANGITIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84862827328     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.387     Document Type: Article

References (33)

1. Podnos YD, Jimenez JC, Wilson SE. Intra-abdominal sepsis in elderly persons. Clin Infect Dis 2002; 35: 62-8. (Pubitemid 34666861)
2. Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin North Am 2000; 14: 521-46.
3. Siegman-Igra Y, Schwartz D, Konforti N et al. Septicemia from biliary tract infection. Arch Surg 1988; 123: 366-8. (Pubitemid 18093309)
4. Sinanan MN. Acute cholangitis. Infect Dis Clin North Am 1992; 6: 571-99.
5. Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin North Am 1990; 70: 1297-312.
6. Gigot JF, Leese T, Dereme T et al. Acute cholangitis. Multivariate analysis of risk factors. Ann Surg 1989; 209: 435-8. (Pubitemid 19106274)
7. Melzer M, Toner R, Lacey S et al. Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes. Postgrad Med J 2007; 83: 773-6.
8. Dooley JS, Hamilton-Miller JM, Brumfitt W et al. Antibiotics in the treatment of biliary infection. Gut 1984; 25: 988-98. (Pubitemid 14040306)
9. Lai EC, Tam PC, Paterson IA et al. Emergency surgery for severe acute cholangitis. The high-risk patients. Ann Surg 1990; 211: 55-9. (Pubitemid 20027883)
10. Thompson Jr JE, Tompkins RK, Longmire Jr WP. Factors in management of acute cholangitis. Ann Surg 1982; 195: 137-45. (Pubitemid 12222873)
11. Liu TJ. Acute biliary septic shock. HPB Surg 1990; 2: 177-83.
12. Wada K, Takada T, Kawarada Y et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007; 14: 52-8. (Pubitemid 46189142)
13. Lee CC, Chang IJ, Lai YC et al. Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis. Am J Gastroenterol 2007; 102: 563-9.
14. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999; 11: 7-12. (Pubitemid 29067411)
15. Chang WT, Lee KT, Wang SR et al. Bacteriology and antimicrobial susceptibility in biliary tract disease: an audit of 10-year's experience. Kaohsiung J Med Sci 2002; 18: 221-8.
16. Spellberg B, Guidos R, Gilbert D et al. The epidemic of antibioticresistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 155-64. (Pubitemid 351269151)
17. Rodriguez-Bano J, Pascual A. Clinical significance of extended-spectrum beta-lactamases. Expert Rev Anti Infect Ther 2008; 6: 671-83.
18. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136: 834-44. (Pubitemid 34568654)
19. Rossi F, Baquero F, Hsueh PR et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006; 58: 205-10. (Pubitemid 44295010)
20. Chen YH, Hsueh PR, Badal RE et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 2011; 62: 280-91.
21. Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 133-64.
22. Wu UI, Yang CS, Chen WC et al. Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli. J Microbiol Immunol Infect 2010; 43: 310-6.
23. Tumbarello M, Spanu T, Sanguinetti M et al. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006; 50: 498-504. (Pubitemid 43190958)
24. Lautenbach E, Patel JB, Bilker WB et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factorsfor infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32: 1162-71. (Pubitemid 32390110)
25. Ortega M, Marco F, Soriano A et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibioticresistant strain and their impact on the outcome. J Antimicrob Chemother 2009; 63: 568-74.
26. Chow JW, Fine MJ, Shlaes DM et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-90.
27. Serefhanoglu K, Turan H, Timurkaynak FE et al. Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance. Braz J Infect Dis 2009; 13: 403-7.
28. Jeon MH, Choi SH, Kwak YG et al. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn Microbiol Infect Dis 2008; 62: 402-6.
29. Kang CI, Kim SH, Park WB et al. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis 2004; 39: 812-8.
30. Kim YK, Pai H, Lee HJ et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002; 46: 1481-91. (Pubitemid 34415332)
31. Blot S, Vandewoude K, De Bacquer D et al. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 2002; 34: 1600-6. (Pubitemid 34615445)
32. Kang CI, Kim SH, Kim DM et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004; 25: 860-7. (Pubitemid 40036764)
33. Kim BN, Woo JH, Kim MN et al. Clinical implications of extendedspectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia. J Hosp Infect 2002; 52: 99-106 .